PR

Pushpa Rangasamy

Director Director DIN 03632902
DIN 03632902 First appointment Oct 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Pushpa Rangasamy

Data last updated:

Pushpa Rangasamy was a Director at Erode Pharma Private Limited (2011–2018) and Designated Partner at Nanbargal Pharma Llp (from 2012). The companies operate in Healthcare.

DIN 03632902
Primary Designation Director
Industry Healthcare
First Appointment 20 Oct 2011
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Erode Pharma Private Limited U52310TZ2010PTC015793
Director20 Oct 20112010₹2.22 Cr (FY 2025)Active
Designated Partner22 Aug 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nanbargal Pharma Llp
Erode Pharma Private Limited
Premium access

Shareholding and investment profile for Pushpa Rangasamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pushpa Rangasamy

Pushpa Rangasamy was first appointed on 20 Oct 2011 as Director at Erode Pharma Private Limited. The most recent appointment on record is 22 Aug 2012 at Nanbargal Pharma Llp.

Pushpa Rangasamy held 2 earlier board appointments: Erode Pharma Private Limited (Director, 20 Oct 2011 to 28 Dec 2018); Nanbargal Pharma Llp (Designated Partner, from 22 Aug 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available